Published in Blood Weekly, November 13th, 2003
R.M. Craig and colleagues at Northwestern University "embarked on a unique therapy for this group of patients, intense immune suppression followed by autologous hematopoietic stem-cell transplantation (HSCT)."
"The response to this approach in our first four patients has been excellent, with there being no significant untoward event from the transplantation and with each patient...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.